Clinical Trials Sponsored by HDT Global

Total 1154 results

HLT Inc.

Terminated

HLT Meridian Valve CE Mark Trial (RADIANT CE)

Aortic Valve Stenosis

Canada
HLT Inc.

Withdrawn

HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA (HORIZON CANADA)

Severe Aortic Stenosis

Canada
HLT Inc.

Withdrawn

HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation (RIVAL - AR EFS)

Aortic Regurgitation

United States
HLT Inc.

Completed

Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA (RADIANT CANADA)

Aortic Valve Stenosis

Canada
HLT Inc.

Terminated

Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial (RADIANT)

Aortic Valve Stenosis

United States
HLT Inc.

Completed

HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON (HORIZON)

Aortic Valve Stenosis | Severe Aortic Stenosis

Germany
Global BioClinical

Withdrawn

Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples (GBCPRT0009)

Cancer

United States
Global D

Recruiting

Study Evaluating the Performance and Safety of Global D Implants Indicated for Trauma Surgery (CMF-TRAUMA)

Trauma Injury | Maxillofacial Trauma | Maxilla Fracture

France
RLS Global

Terminated

Evaluate Efficacy and Safety of ChloraSolv When Treating Pressure Ulcers in Need of Debridement

Pressure Ulcer

Sweden, United Kingdom, Aland Islands
Global BioClinical

Withdrawn

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples (GBCPRT0008)

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Hematologic Cancer

United States
Global Biotech

Completed

Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.

Cerebrovascular Accident

Taiwan
Global D

Recruiting

Study Evaluating the Performance and Safety in the Medium and Long Term of Global D Implant-prosthetic Systems

Dental Implants

France, Greece
RLS Global

Terminated

A PMCF Investigation on Chronic LU and DFU in Need of Debridement With ChloraSolv® (ChloraSolv02)

Chronic Diabetic Foot Ulcer | Chronic Leg Ulcer

Sweden
Global D

Active, not recruiting

Study Evaluating the Performance and Safety of Global D Implants Indicated for Orthognathic Surgery (CMF-ORTHO)

Maxillofacial Abnormalities | Orthognathic Surgery | Maxilla Fracture

France
RLS Global

Completed

An Open, Single-arm, Multi Centre Pilot Investigation to Evaluate the Debriding Effect of ChloraSolv® on Chronic Wounds

Chronic Ulcer at Lower Leg

Sweden
Weprom
SIVAN Innovation Ldt

Completed

SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse (SENTINEL)

Lung Cancer

France
HDH Medical Ltd

Completed

Safety and Efficacy of Using HDH Device and Method - a Novel Sutureless Vascular Anastomosis

Atherosclerosis | Vascular Disease

Israel
HDT Bio
Kaiser Permanente; Rainier Clinical Research Center; C3 Research Associates

Active, not recruiting

Safety And Immunogenicity Of HDT-301 Targeting A SARS-CoV-2 Variant Spike Protein

SARS-CoV2 Infection

United States
Ophthalmic PDT Study Group

Completed

PDT Study for Exudative AMD With PCV

Age Related Macular Degeneration

Japan
Global Kinetics Corporation

Recruiting

Personal KinetiGraph® Clinical Validation Study

Parkinson Disease | Movement Disorders

United States
Global Neurosciences Institute

Recruiting

Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme

Glioblastoma Multiforme

United States
ProgenaCare Global, LLC

Active, not recruiting

Efficacy of ProgenaMatrix™ in the Management of DFUs

Diabetic Foot Ulcer

United States
Global Kinetics Corporation

Withdrawn

Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG (TARGET-PwP)

Parkinson Disease
Global Surgery Amsterdam

Completed

From Short-term Surgical Missions Towards Sustainable Partnerships

Global Surgery | Medical Missions

Netherlands
Global Blood Therapeutics

Terminated

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest (Zephyr)

Idiopathic Pulmonary Fibrosis | Hypoxemia

United Kingdom, United States
Global Blood Therapeutics

Completed

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

Renal Impairment

United States
Global Blood Therapeutics

Completed

A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects

Sickle Cell Disease

United States
Global Blood Therapeutics

Completed

A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects

Anemia, Sickle Cell

United States
Hat Yai Medical Education Center

Completed

Awareness of Iron Status Evaluation in UGIB (AISE)

Upper Gastrointestinal Bleeding

Thailand
Hat Yai Medical Education Center

Completed

Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma

Asthma

Thailand
Cohen Global, Ltd.

Not yet recruiting

Subcutaneous Administration of MD-18 in Healthy Subjects

Healthy Volunteers
Global Neurosciences Institute

Recruiting

Verapamil for Neuroprotection in Stroke

Ischemic Stroke

United States
Global Cell Med

Unknown

Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients

Diabetes Complications | Diabetes Mellitus Progression

Bahamas
Zoe Global Limited

Active, not recruiting

ZOE's Ferment Experiment (ZHS-FE)

Mood | Hunger | Energy

United Kingdom
Global Kinetics Corporation

Active, not recruiting

Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status (APPRISE)

Parkinson Disease

United States
Aspen Global Incorporated

Terminated

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban (HITSOVA)

Heparin-induced Thrombocytopenia

United States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
Global Kinetics Corporation

Terminated

Utilization of Target Ranges to Treat Parkinson's Disease With the PKG (TARGET-PD)

Parkinson Disease

United States
Global Blood Therapeutics

Completed

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF

Idiopathic Pulmonary Fibrosis | Hypoxemia

United States
WCCT Global
Vaxart

Completed

Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model

Norovirus Infection

United States
Aspen Global Incorporated

Completed

A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

Injection Site Reaction
Global Blood Therapeutics

Completed

An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001

Sickle Cell Disease

United Kingdom
Global Blood Therapeutics

Completed

A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease

Sickle Cell Disease | Healthy Subjects

United Kingdom
Global Blood Therapeutics

Completed

Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects

Sickle Cell Disease

United States
MedLogic Global Limited

Completed

Clinical Trial of MedLogic LiquiBand Laparoscopic Versus Dermabond in the Closure of Surgical Incisions

Laparoscopic Surgery

United Kingdom
Hat Yai Medical Education Center

Completed

The Correlations of FeNO, Blood Eosinophils and Lung Function in Well-controlled Asthma

Asthma

Thailand
PepsiCo Global R&D

Recruiting

Transdermal Optical Imaging (TOI) as a Non-invasive Measure to Detect Changes in Hydration Status in Healthy Adults and Athletes

Dehydration

United States
PepsiCo Global R&D

Recruiting

Aspire2B Personalization Pilot Study Program

Behavior | Lifestyle | App Proficiency

United States
PepsiCo Global R&D

Recruiting

Effect of Glycerol-Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest

Hydration

United States
Riverpoint Medical
Global CRO

Not yet recruiting

JuggerKnot With Broadband PMCF Study

Shoulder Injuries | Knee Injuries | Hip Injuries | Ankle Injuries | Foot Injury
Global Alzheimer's Platform Foundation

Recruiting

Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)

Alzheimer Disease | Mild Cognitive Impairment | Memory Disorders | Memory Impairment | Memory Loss

United States, Canada

3

Subscribe